Company Overview and News
This was a big week in IPO news for both Uber Technologies Inc. and Lyft Inc., as each edges toward its eagerly awaited public market debut. So far, there have been some striking similarities between the companies’ stories (e.g. the timing and the lack of profits), but there are key differences too. As it preps for the big event, Lyft has been stressing its gains in ride-hailing. Uber, meanwhile, is trumpeting just about everything else.
DGLD CS GS UGLD GLSSP MS JBK DSLV VIIX GSC CSSLF VIIZ TFG GSJ CSGKF ZIV USLV GJS TVIX XIV
(Oct 18): ABB Ltd is working with advisers to prepare the potential separation of its power grid unit, people familiar with the matter said, which would be a strong indication the Swiss engineering company may divest the business worth more than US$10 billion.
DGLD CS GS UGLD GLSSP ABLZF JBK DSLV VIIX GSC CSSLF VIIZ TFG GSJ CSGKF ABB ZIV USLV TVIX GJS XIV
(Oct 18): The Treasury Department stopped short of declaring China a currency manipulator in its semi-annual report on foreign-exchange rates, averting an escalation of a trade war while serving notice that the U.S. will closely watch the yuan after its recent slide.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV
NEW YORK – Uber Technologies Inc. is eyeing a valuation above $100 billion for its much-anticipated share offering due in 2019, which would be the biggest-ever in the tech sector, sources familiar with the plan said Tuesday.
DGLD TM SFTBF CS GS GLSSP UGLD JEF MS GM SFTBY JBK DSLV VIIX GSC CSSLF VIIZ TFG TYT TOYOF GSJ CSGKF 7203 ZIV USLV 9984 TVIX GJS XIV
NEW YORK (Reuters) - JP Morgan & Chase Co (JPM.N) Chief Executive Jamie Dimon and Ford Motor Co (F.N) Chairman Bill Ford canceled plans to attend a Saudi investor conference, the companies said on Sunday, the latest such high-profile announcements after the disappearance of Saudi journalist Jamal Khashoggi.
GLSSP UGLD VIAB STAN SCBFF JBK DSLV CSSLF TFG CGBBW 2888 STAN DGLD CCF CS GS STAB STAC VIA C VIIX GSC VIIZ MA NYTAB GSJ CSGKF 580001 ZIV USLV TVIX GJS XIV
There's little satisfaction writing the CBB after a big down week in the markets. Motivation seems easier to come by after up weeks, perhaps my defiant streak kicking in. I find myself especially melancholy at the end of this week. There's a rude awakening coming - perhaps it's finally starting to unfold.
DGLD BATS 4162 CS FMCKI FMCKJ UGLD SCGLF UBS FMCCO FMCCP DSLV FMCCM VIIX FMCCN CSSLF VIIZ FMCCI FMCCJ SCGLY FMCCG FMCKO NYTAB FMCKP FMCKM FMCKN FMCKK FMCKL CSGKF NDAQ T FMCC 2007 ZIV USLV GLE TVIX FMCCS ULSGF FMCCT XIV
(Oct 12): The souring of U.S.-China relations amid rising trade tensions and hardware hacks are putting to test the dominance of technology companies on Asian stock markets.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV
CAIRO (Oct 11): Egypt struck a deal to get US$3.8 billion in new financing from an international consortium that includes Deutsche Bank AG and HSBC Bank Plc to boost its foreign-currency stockpile at a time when an emerging-market selloff is spooking investors.
11IE DSLV DB VIIX DGLD 42KM CSSLF VIIZ CS CSGKF UGLD 42MA ZIV USLV TVIX XIV
ASIA’S dollar bond sales are set to end 2018 with a whimper after a sizzling start. Next year’s prospects may prove dimmer, bankers and investors say.
DSLV VIIX DGLD CSSLF VIIZ NAB NASXF NABZY CS NAUBF CSGKF UGLD ZIV USLV TVIX XIV
Oakmark Global Fund – Investor Class Average Annual Total Returns (09/30/18) Since Inception (08/04/99) 10.18% 10–year 8.44% 5–year 6.33% 1–year 1.02% 3–month 0.09% Gross Expense Ratio as of 09/30/17 was 1.21% Net Expense Ratio as of 09/30/17 was 1.15%
NOV TPK MLUSG UGLD LLOBF RYAAY MTUAY MTUAF GE DSLV CSSLF USGPF ARNC DDAIF JBAXY GOOGL LLDTF TPRKY DGLD GOOG IPG CS BAC TVPKF GM USG ORCL JBARF GEC LLOY VIIX VIIZ RYAOF MA LYG NAPRF LLPH CSGKF LLPK LLPJ LLPE LLPD LLPG LLD5 GNE ZIV LLD7 LLPC USLV LLD6 TVIX LLD1 THC TV LLD2 XIV
The fastest pace of growth since 2013 at India’s non-bank financiers is about to come to a grinding halt. A spate of money market defaults by Infrastructure Leasing & Financial Services Ltd. has put the spotlight on non-bank finance companies. With banks struggling with bad loans and low capital buffers, non-bank lenders had rushed to tap demand for long-term financing to build roads, power plants and homes.
DSLV EDELWEISS VIIX DGLD CSSLF VIIZ IIFL 532922 532636 SRTRANSFIN CS 511218 CSGKF UGLD MAGMA SRRQY ZIV USLV 524000 TVIX XIV
But as the biggest U.S. banks report results that analysts estimate will set a new high for profitability this decade, shareholders are wondering: is this as good as gets, or is Jamie Dimon right that banks are entering a golden age.
BCS 83SF UGLD 83SK DSLV CSSLF CGBBW WFCNP DGLD CS 47MC WFC C VIIX VIIZ CSGKF ZIV USLV TVIX XIV
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to CS / Credit Suisse Group on message board site Silicon Investor.
as of ET